Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

A Prospective Analysis of Red and Processed Meat Consumption and Risk of Colorectal Cancer in Women.

Mehta SS, Arroyave WD, Lunn RM, Park YM, Boyd WA, Sandler DP.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):141-150. doi: 10.1158/1055-9965.EPI-19-0459. Epub 2019 Oct 1.

PMID:
31575555
2.

Comprehensive Analyses and Prioritization of Tox21 10K Chemicals Affecting Mitochondrial Function by in-Depth Mechanistic Studies.

Xia M, Huang R, Shi Q, Boyd WA, Zhao J, Sun N, Rice JR, Dunlap PE, Hackstadt AJ, Bridge MF, Smith MV, Dai S, Zheng W, Chu PH, Gerhold D, Witt KL, DeVito M, Freedman JH, Austin CP, Houck KA, Thomas RS, Paules RS, Tice RR, Simeonov A.

Environ Health Perspect. 2018 Jul 26;126(7):077010. doi: 10.1289/EHP2589. eCollection 2018 Jul.

3.

Circadian Health and Light: A Report on the National Heart, Lung, and Blood Institute's Workshop.

Mason IC, Boubekri M, Figueiro MG, Hasler BP, Hattar S, Hill SM, Nelson RJ, Sharkey KM, Wright KP, Boyd WA, Brown MK, Laposky AD, Twery MJ, Zee PC.

J Biol Rhythms. 2018 Oct;33(5):451-457. doi: 10.1177/0748730418789506. Epub 2018 Jul 23.

4.

Health consequences of electric lighting practices in the modern world: A report on the National Toxicology Program's workshop on shift work at night, artificial light at night, and circadian disruption.

Lunn RM, Blask DE, Coogan AN, Figueiro MG, Gorman MR, Hall JE, Hansen J, Nelson RJ, Panda S, Smolensky MH, Stevens RG, Turek FW, Vermeulen R, Carreón T, Caruso CC, Lawson CC, Thayer KA, Twery MJ, Ewens AD, Garner SC, Schwingl PJ, Boyd WA.

Sci Total Environ. 2017 Dec 31;607-608:1073-1084. doi: 10.1016/j.scitotenv.2017.07.056. Epub 2017 Jul 27. Review.

5.

Editor's Highlight: Comparative Toxicity of Organophosphate Flame Retardants and Polybrominated Diphenyl Ethers to Caenorhabditis elegans.

Behl M, Rice JR, Smith MV, Co CA, Bridge MF, Hsieh JH, Freedman JH, Boyd WA.

Toxicol Sci. 2016 Dec;154(2):241-252. Epub 2016 Aug 26.

6.

Developmental Effects of the ToxCast™ Phase I and Phase II Chemicals in Caenorhabditis elegans and Corresponding Responses in Zebrafish, Rats, and Rabbits.

Boyd WA, Smith MV, Co CA, Pirone JR, Rice JR, Shockley KR, Freedman JH.

Environ Health Perspect. 2016 May;124(5):586-93. doi: 10.1289/ehp.1409645. Epub 2015 Oct 23.

7.

Use of alternative assays to identify and prioritize organophosphorus flame retardants for potential developmental and neurotoxicity.

Behl M, Hsieh JH, Shafer TJ, Mundy WR, Rice JR, Boyd WA, Freedman JH, Hunter ES 3rd, Jarema KA, Padilla S, Tice RR.

Neurotoxicol Teratol. 2015 Nov-Dec;52(Pt B):181-93. doi: 10.1016/j.ntt.2015.09.003. Epub 2015 Sep 18.

PMID:
26386178
8.

Comparison of the toxicity of fluoridation compounds in the nematode Caenorhabditis elegans.

Rice JR, Boyd WA, Chandra D, Smith MV, Den Besten PK, Freedman JH.

Environ Toxicol Chem. 2014 Jan;33(1):82-8. doi: 10.1002/etc.2394.

PMID:
24105802
9.

Caenorhabditis elegans as a model in developmental toxicology.

Boyd WA, Smith MV, Freedman JH.

Methods Mol Biol. 2012;889:15-24. doi: 10.1007/978-1-61779-867-2_3.

10.

Amelioration of metal-induced toxicity in Caenorhabditis elegans: utility of chelating agents in the bioremediation of metals.

Harrington JM, Boyd WA, Smith MV, Rice JR, Freedman JH, Crumbliss AL.

Toxicol Sci. 2012 Sep;129(1):49-56. doi: 10.1093/toxsci/kfs191. Epub 2012 May 28.

11.

Integrating HIV prevention in reproductive health settings.

Zotti ME, Pringle J, Stuart G, Boyd WA, Brantley D, de Ravello L.

J Public Health Manag Pract. 2010 Nov-Dec;16(6):512-20. doi: 10.1097/PHH.0b013e3181ef1935.

PMID:
20885181
12.

Caenorhabditis elegans generates biologically relevant levels of genotoxic metabolites from aflatoxin B1 but not benzo[a]pyrene in vivo.

Leung MC, Goldstone JV, Boyd WA, Freedman JH, Meyer JN.

Toxicol Sci. 2010 Dec;118(2):444-53. doi: 10.1093/toxsci/kfq295. Epub 2010 Sep 23.

13.

Molecular characterization of numr-1 and numr-2: genes that increase both resistance to metal-induced stress and lifespan in Caenorhabditis elegans.

Tvermoes BE, Boyd WA, Freedman JH.

J Cell Sci. 2010 Jun 15;123(Pt 12):2124-34. doi: 10.1242/jcs.065433. Epub 2010 May 25.

14.

A high-throughput method for assessing chemical toxicity using a Caenorhabditis elegans reproduction assay.

Boyd WA, McBride SJ, Rice JR, Snyder DW, Freedman JH.

Toxicol Appl Pharmacol. 2010 Jun 1;245(2):153-9. doi: 10.1016/j.taap.2010.02.014. Epub 2010 Mar 4.

15.

Nucleotide excision repair genes are expressed at low levels and are not detectably inducible in Caenorhabditis elegans somatic tissues, but their function is required for normal adult life after UVC exposure.

Boyd WA, Crocker TL, Rodriguez AM, Leung MC, Lehmann DW, Freedman JH, Van Houten B, Meyer JN.

Mutat Res. 2010 Jan 5;683(1-2):57-67. doi: 10.1016/j.mrfmmm.2009.10.008.

16.

A discrete time model for the analysis of medium-throughput C. elegans growth data.

Smith MV, Boyd WA, Kissling GE, Rice JR, Snyder DW, Portier CJ, Freedman JH.

PLoS One. 2009 Sep 15;4(9):e7018. doi: 10.1371/journal.pone.0007018.

17.

Application of a mathematical model to describe the effects of chlorpyrifos on Caenorhabditis elegans development.

Boyd WA, Smith MV, Kissling GE, Rice JR, Snyder DW, Portier CJ, Freedman JH.

PLoS One. 2009 Sep 15;4(9):e7024. doi: 10.1371/journal.pone.0007024.

18.

Medium- and high-throughput screening of neurotoxicants using C. elegans.

Boyd WA, Smith MV, Kissling GE, Freedman JH.

Neurotoxicol Teratol. 2010 Jan-Feb;32(1):68-73. doi: 10.1016/j.ntt.2008.12.004. Epub 2009 Jan 6.

19.

Use of non-mammalian alternative models for neurotoxicological study.

Peterson RT, Nass R, Boyd WA, Freedman JH, Dong K, Narahashi T.

Neurotoxicology. 2008 May;29(3):546-55. doi: 10.1016/j.neuro.2008.04.006. Epub 2008 Apr 25. Review.

20.

Identification of innate immunity genes and pathways using a comparative genomics approach.

Alper S, Laws R, Lackford B, Boyd WA, Dunlap P, Freedman JH, Schwartz DA.

Proc Natl Acad Sci U S A. 2008 May 13;105(19):7016-21. doi: 10.1073/pnas.0802405105. Epub 2008 May 7.

21.

Molecular characterization of two homologs of the Caenorhabditis elegans cadmium-responsive gene cdr-1: cdr-4 and cdr-6.

Dong J, Boyd WA, Freedman JH.

J Mol Biol. 2008 Feb 22;376(3):621-33. doi: 10.1016/j.jmb.2007.11.094. Epub 2007 Dec 5.

23.
24.

Decline of nucleotide excision repair capacity in aging Caenorhabditis elegans.

Meyer JN, Boyd WA, Azzam GA, Haugen AC, Freedman JH, Van Houten B.

Genome Biol. 2007;8(5):R70.

25.

Using transgenic Caenorhabditis elegans in soil toxicity testing.

Graves AL, Boyd WA, Williams PL.

Arch Environ Contam Toxicol. 2005 May;48(4):490-4. Epub 2005 Mar 24.

PMID:
15886897
26.

The effects of metals and food availability on the behavior of Caenorhabditis elegans.

Boyd WA, Cole RD, Anderson GL, Williams PL.

Environ Toxicol Chem. 2003 Dec;22(12):3049-55.

PMID:
14713049
27.
28.
29.

Assessment of sublethal endpoints for toxicity testing with the nematode Caenorhabditis elegans.

Anderson GL, Boyd WA, Williams PL.

Environ Toxicol Chem. 2001 Apr;20(4):833-8.

PMID:
11345460
30.

Effects of dextran sulfate on tracheal mucociliary velocity in dogs.

Sudo E, Boyd WA, King M.

J Aerosol Med. 2000 Summer;13(2):87-96.

PMID:
11010598
31.

Effects of methacholine and uridine 5'-triphosphate on tracheal mucus rheology in mice.

Sudo E, Lee MM, Boyd WA, King M.

Am J Respir Cell Mol Biol. 2000 Mar;22(3):373-9.

PMID:
10696075
32.

Effects of combined treatment with rhDNase and airflow oscillations on spinnability of cystic fibrosis sputum in vitro.

Dasgupta B, Tomkiewicz RP, Boyd WA, Brown NE, King M.

Pediatr Pulmonol. 1995 Aug;20(2):78-82.

PMID:
8570306
33.
34.
35.

Intravenous regional anesthesia.

Boyd WA, Robinson JG.

J Fam Pract. 1974 May;1(1):60-3. No abstract available.

PMID:
4452849
36.

Cardiorespiratory and pathologic changes during transtracheal ventilation in dogs.

McDermott RW, Boyd WA.

Arch Surg. 1973 Sep;107(3):452-5. No abstract available.

PMID:
4783040
37.

Cardiovascular effects of three technics for inducing hypotension during anesthesia.

Jordan WS, Graves CL, Boyd WA, Ueda I, Roberts TS.

Anesth Analg. 1971 Nov-Dec;50(6):1059-68. No abstract available.

PMID:
5166894
38.

Adenosine triphosphatase activities of subcellular fractions of normal and ischemic muscles.

Kohama A, Boyd WA, Ballinger CM, Ueda I.

J Surg Res. 1971 Jun;11(6):297-302. No abstract available.

PMID:
4254529
39.

The use of continuous solvent evaporation in the automated analysis of Amprol Plus.

Feller B, Boyd WA, Di Dario BE, Ferrari A.

Ann N Y Acad Sci. 1968 Nov 15;153(2):428-45. No abstract available.

PMID:
5259838
40.

The use of a digital computer as an aid to patient care in the operating room.

Boyd WA.

South Med J. 1966 Mar;59(3):276. No abstract available.

PMID:
5910626
41.

EVALUATION OF A BEDSIDE MONITORING SYSTEM.

BOYD WA.

South Med J. 1965 Aug;58:1041-3. No abstract available.

PMID:
14315422
42.

An "ideal" monitoring system to aid patient care.

Boyd WA.

Int Anesthesiol Clin. 1965 May;3(3):513-22. No abstract available.

PMID:
5834987
43.

Use of a digital computer as an aid to patient care in the operating room.

Boyd WA.

Int Anesthesiol Clin. 1965 May;3(3):505-6. No abstract available.

PMID:
5834985
44.

Evaluation of a bedside monitoring system.

Boyd WA.

Int Anesthesiol Clin. 1965 May;3(3):489-95. No abstract available.

PMID:
5834983
45.

Blood pressure monitoring.

Boyd WA.

Int Anesthesiol Clin. 1965 May;3(3):417-33. No abstract available.

PMID:
5834979
46.

An attempt to produce mutations by sound.

FRINGS H, BOYD WA.

Experientia. 1951 Nov;7(11):424. No abstract available.

PMID:
14936997

Supplemental Content

Support Center